Fabrinet: Robust Revenue, But Cash Flow and Capacity Expansion Remain Critical

What happened

Fabrinet reported fiscal Q1 2027 revenue of $1.474 billion, a 51% year-over-year increase, driven primarily by data center demand that now comprises 52.7% of sales. Management guided to Q2 revenue of $1.60–1.65 billion, implying continued strong growth, but the company's operating cash flow fell to only $21.3 million, while inventory jumped to $1.193 billion and capital expenditures reached $158.7 million. The Seeking Alpha analyst upgraded Fabrinet from sell to hold, noting that fundamentals and valuation have improved, with the stock now trading near fair value after a sharp decline from earlier peaks. DeepValue's master report maintains a WAIT rating with a base-case implied value of $320, emphasizing that the key unresolved issue is whether the heavy inventory and capex can convert back into cash over the next one to two quarters. Both sources agree that demand remains robust, but the stock's risk-reward is balanced, with upside contingent on cash flow normalization and successful capacity absorption.

Implication

The near-term risk is that heavy capital spending and negative free cash flow may persist if capacity expansion outpaces demand, potentially pressuring the stock further. Fabrinet's strong revenue growth and stable operating margins provide a solid foundation, but at 21.8x earnings and 16.3x EV/EBITDA, the valuation already discounts much of the good news. A key catalyst will be the Q2 FY27 report, where meeting the revenue guide and showing a material improvement in operating cash flow could validate the investment and support a higher price. Failure to convert working capital into cash, or any pause in orders from major customers like Cisco, Nvidia, or Amazon, could lead to a further derating toward the bear-case value of $240. For long-term investors, attractive entry is near $255, while trimming above $360 is prudent; patience is warranted until clearer signs of self-funding growth emerge.

Thesis delta

The thesis has shifted from a sell to a hold/neutral stance as Fabrinet's fundamentals and valuation have improved following strong Q1 results. However, the core risk remains the company's ability to convert elevated inventory and capex into operating cash flow, which is not yet proven. Our outlook is now balanced rather than bearish, but we require evidence of cash conversion before turning constructive.